[ad_1]
The content of the active ingredients of valsartan in antihypertensive drugs or the lowering of high blood pressure is considered dangerous and potentially carcinogenic.
"As part of the protection of public health, BPOM RI has asked the pharmaceutical industry to stop the production and distribution of drugs containing valsartan from Zhejiang Huahai Pharmaceuticals, Linhai, China" , writes BPOM on its official website [19659003] "Valsartan's products that do not use the raw materials of the aforementioned producers can still be consumed by the community."
Valsartan is a drug or a hard drug that must be consumed on prescription from a doctor. It is used in patients with high blood pressure, whether alone or in combination with other antihypertensive drugs.
"Valsartan is indicated to reduce the risk of stroke and heart complications, and it is also used in people with heart failure or having recently suffered a heart attack," writes BPOM.
. receptor blockers (ARB). This medication will work by calming the blood vessels so that the blood circulates more easily.
Antihypertensive drugs containing valsartan raw materials manufactured in Chinese factories were also removed in some European Union countries to find impurities Nitrosodimethylamine (NDMA).
Nitrosodimethylamine itself is toxic, particularly for the human liver. These chemical compounds are also known as human carcinogens.
In high doses tested in laboratory mice, NDMA is a potential hepatotoxin and may cause fibrosis in the liver. The incidence of tumors in the liver after chronic exposure to low doses also appears in the study.
It's just that the withdrawal of this antihypertensive is only done on antihypertensive drugs containing valsartan production from the Chinese plant.
(chs)
[ad_2]
Source link
